[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Amfepramone(Diethylpropion) API Market Growth 2023-2029

February 2023 | 118 pages | ID: GD741F61ACFFEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Amfepramone, also known as diethylpropion, is a stimulant drug of the phenethylamine, amphetamine, and cathinone classes that is used as an appetite suppressant

LPI (LP Information)' newest research report, the “Amfepramone(Diethylpropion) API Industry Forecast” looks at past sales and reviews total world Amfepramone(Diethylpropion) API sales in 2022, providing a comprehensive analysis by region and market sector of projected Amfepramone(Diethylpropion) API sales for 2023 through 2029. With Amfepramone(Diethylpropion) API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amfepramone(Diethylpropion) API industry.

This Insight Report provides a comprehensive analysis of the global Amfepramone(Diethylpropion) API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amfepramone(Diethylpropion) API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amfepramone(Diethylpropion) API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amfepramone(Diethylpropion) API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amfepramone(Diethylpropion) API.

The global Amfepramone(Diethylpropion) API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Amfepramone(Diethylpropion) API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Amfepramone(Diethylpropion) API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Amfepramone(Diethylpropion) API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Amfepramone(Diethylpropion) API players cover Avantor, Sanofi, Pfizer, Arevipharma, Fiore, ACS Dobfar, Tiefenbacher Group, Varda Biotec and Toronto Research Chemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Amfepramone(Diethylpropion) API market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Barreled
  • Bags
Segmentation by application
  • Appetite Suppressant
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Avantor
  • Sanofi
  • Pfizer
  • Arevipharma
  • Fiore
  • ACS Dobfar
  • Tiefenbacher Group
  • Varda Biotec
  • Toronto Research Chemicals
  • Radiant Pharma
  • Overlack
  • Jigs Chemical
  • Biosynt
  • Amfinecom
  • USV
Key Questions Addressed in this Report

What is the 10-year outlook for the global Amfepramone(Diethylpropion) API market?

What factors are driving Amfepramone(Diethylpropion) API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Amfepramone(Diethylpropion) API market opportunities vary by end market size?

How does Amfepramone(Diethylpropion) API break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Amfepramone(Diethylpropion) API Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Amfepramone(Diethylpropion) API by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Amfepramone(Diethylpropion) API by Country/Region, 2018, 2022 & 2029
2.2 Amfepramone(Diethylpropion) API Segment by Type
  2.2.1 Barreled
  2.2.2 Bags
2.3 Amfepramone(Diethylpropion) API Sales by Type
  2.3.1 Global Amfepramone(Diethylpropion) API Sales Market Share by Type (2018-2023)
  2.3.2 Global Amfepramone(Diethylpropion) API Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Amfepramone(Diethylpropion) API Sale Price by Type (2018-2023)
2.4 Amfepramone(Diethylpropion) API Segment by Application
  2.4.1 Appetite Suppressant
  2.4.2 Others
2.5 Amfepramone(Diethylpropion) API Sales by Application
  2.5.1 Global Amfepramone(Diethylpropion) API Sale Market Share by Application (2018-2023)
  2.5.2 Global Amfepramone(Diethylpropion) API Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Amfepramone(Diethylpropion) API Sale Price by Application (2018-2023)

3 GLOBAL AMFEPRAMONE(DIETHYLPROPION) API BY COMPANY

3.1 Global Amfepramone(Diethylpropion) API Breakdown Data by Company
  3.1.1 Global Amfepramone(Diethylpropion) API Annual Sales by Company (2018-2023)
  3.1.2 Global Amfepramone(Diethylpropion) API Sales Market Share by Company (2018-2023)
3.2 Global Amfepramone(Diethylpropion) API Annual Revenue by Company (2018-2023)
  3.2.1 Global Amfepramone(Diethylpropion) API Revenue by Company (2018-2023)
  3.2.2 Global Amfepramone(Diethylpropion) API Revenue Market Share by Company (2018-2023)
3.3 Global Amfepramone(Diethylpropion) API Sale Price by Company
3.4 Key Manufacturers Amfepramone(Diethylpropion) API Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Amfepramone(Diethylpropion) API Product Location Distribution
  3.4.2 Players Amfepramone(Diethylpropion) API Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR AMFEPRAMONE(DIETHYLPROPION) API BY GEOGRAPHIC REGION

4.1 World Historic Amfepramone(Diethylpropion) API Market Size by Geographic Region (2018-2023)
  4.1.1 Global Amfepramone(Diethylpropion) API Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Amfepramone(Diethylpropion) API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amfepramone(Diethylpropion) API Market Size by Country/Region (2018-2023)
  4.2.1 Global Amfepramone(Diethylpropion) API Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Amfepramone(Diethylpropion) API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amfepramone(Diethylpropion) API Sales Growth
4.4 APAC Amfepramone(Diethylpropion) API Sales Growth
4.5 Europe Amfepramone(Diethylpropion) API Sales Growth
4.6 Middle East & Africa Amfepramone(Diethylpropion) API Sales Growth

5 AMERICAS

5.1 Americas Amfepramone(Diethylpropion) API Sales by Country
  5.1.1 Americas Amfepramone(Diethylpropion) API Sales by Country (2018-2023)
  5.1.2 Americas Amfepramone(Diethylpropion) API Revenue by Country (2018-2023)
5.2 Americas Amfepramone(Diethylpropion) API Sales by Type
5.3 Americas Amfepramone(Diethylpropion) API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Amfepramone(Diethylpropion) API Sales by Region
  6.1.1 APAC Amfepramone(Diethylpropion) API Sales by Region (2018-2023)
  6.1.2 APAC Amfepramone(Diethylpropion) API Revenue by Region (2018-2023)
6.2 APAC Amfepramone(Diethylpropion) API Sales by Type
6.3 APAC Amfepramone(Diethylpropion) API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Amfepramone(Diethylpropion) API by Country
  7.1.1 Europe Amfepramone(Diethylpropion) API Sales by Country (2018-2023)
  7.1.2 Europe Amfepramone(Diethylpropion) API Revenue by Country (2018-2023)
7.2 Europe Amfepramone(Diethylpropion) API Sales by Type
7.3 Europe Amfepramone(Diethylpropion) API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Amfepramone(Diethylpropion) API by Country
  8.1.1 Middle East & Africa Amfepramone(Diethylpropion) API Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Amfepramone(Diethylpropion) API Revenue by Country (2018-2023)
8.2 Middle East & Africa Amfepramone(Diethylpropion) API Sales by Type
8.3 Middle East & Africa Amfepramone(Diethylpropion) API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amfepramone(Diethylpropion) API
10.3 Manufacturing Process Analysis of Amfepramone(Diethylpropion) API
10.4 Industry Chain Structure of Amfepramone(Diethylpropion) API

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Amfepramone(Diethylpropion) API Distributors
11.3 Amfepramone(Diethylpropion) API Customer

12 WORLD FORECAST REVIEW FOR AMFEPRAMONE(DIETHYLPROPION) API BY GEOGRAPHIC REGION

12.1 Global Amfepramone(Diethylpropion) API Market Size Forecast by Region
  12.1.1 Global Amfepramone(Diethylpropion) API Forecast by Region (2024-2029)
  12.1.2 Global Amfepramone(Diethylpropion) API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amfepramone(Diethylpropion) API Forecast by Type
12.7 Global Amfepramone(Diethylpropion) API Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Avantor
  13.1.1 Avantor Company Information
  13.1.2 Avantor Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.1.3 Avantor Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Avantor Main Business Overview
  13.1.5 Avantor Latest Developments
13.2 Sanofi
  13.2.1 Sanofi Company Information
  13.2.2 Sanofi Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.2.3 Sanofi Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Sanofi Main Business Overview
  13.2.5 Sanofi Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.3.3 Pfizer Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Arevipharma
  13.4.1 Arevipharma Company Information
  13.4.2 Arevipharma Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.4.3 Arevipharma Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Arevipharma Main Business Overview
  13.4.5 Arevipharma Latest Developments
13.5 Fiore
  13.5.1 Fiore Company Information
  13.5.2 Fiore Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.5.3 Fiore Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Fiore Main Business Overview
  13.5.5 Fiore Latest Developments
13.6 ACS Dobfar
  13.6.1 ACS Dobfar Company Information
  13.6.2 ACS Dobfar Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.6.3 ACS Dobfar Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 ACS Dobfar Main Business Overview
  13.6.5 ACS Dobfar Latest Developments
13.7 Tiefenbacher Group
  13.7.1 Tiefenbacher Group Company Information
  13.7.2 Tiefenbacher Group Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.7.3 Tiefenbacher Group Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Tiefenbacher Group Main Business Overview
  13.7.5 Tiefenbacher Group Latest Developments
13.8 Varda Biotec
  13.8.1 Varda Biotec Company Information
  13.8.2 Varda Biotec Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.8.3 Varda Biotec Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Varda Biotec Main Business Overview
  13.8.5 Varda Biotec Latest Developments
13.9 Toronto Research Chemicals
  13.9.1 Toronto Research Chemicals Company Information
  13.9.2 Toronto Research Chemicals Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.9.3 Toronto Research Chemicals Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Toronto Research Chemicals Main Business Overview
  13.9.5 Toronto Research Chemicals Latest Developments
13.10 Radiant Pharma
  13.10.1 Radiant Pharma Company Information
  13.10.2 Radiant Pharma Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.10.3 Radiant Pharma Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Radiant Pharma Main Business Overview
  13.10.5 Radiant Pharma Latest Developments
13.11 Overlack
  13.11.1 Overlack Company Information
  13.11.2 Overlack Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.11.3 Overlack Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Overlack Main Business Overview
  13.11.5 Overlack Latest Developments
13.12 Jigs Chemical
  13.12.1 Jigs Chemical Company Information
  13.12.2 Jigs Chemical Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.12.3 Jigs Chemical Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Jigs Chemical Main Business Overview
  13.12.5 Jigs Chemical Latest Developments
13.13 Biosynt
  13.13.1 Biosynt Company Information
  13.13.2 Biosynt Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.13.3 Biosynt Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Biosynt Main Business Overview
  13.13.5 Biosynt Latest Developments
13.14 Amfinecom
  13.14.1 Amfinecom Company Information
  13.14.2 Amfinecom Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.14.3 Amfinecom Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Amfinecom Main Business Overview
  13.14.5 Amfinecom Latest Developments
13.15 USV
  13.15.1 USV Company Information
  13.15.2 USV Amfepramone(Diethylpropion) API Product Portfolios and Specifications
  13.15.3 USV Amfepramone(Diethylpropion) API Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 USV Main Business Overview
  13.15.5 USV Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Amfepramone(Diethylpropion) API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amfepramone(Diethylpropion) API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Barreled
Table 4. Major Players of Bags
Table 5. Global Amfepramone(Diethylpropion) API Sales by Type (2018-2023) & (Tons)
Table 6. Global Amfepramone(Diethylpropion) API Sales Market Share by Type (2018-2023)
Table 7. Global Amfepramone(Diethylpropion) API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Amfepramone(Diethylpropion) API Revenue Market Share by Type (2018-2023)
Table 9. Global Amfepramone(Diethylpropion) API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Amfepramone(Diethylpropion) API Sales by Application (2018-2023) & (Tons)
Table 11. Global Amfepramone(Diethylpropion) API Sales Market Share by Application (2018-2023)
Table 12. Global Amfepramone(Diethylpropion) API Revenue by Application (2018-2023)
Table 13. Global Amfepramone(Diethylpropion) API Revenue Market Share by Application (2018-2023)
Table 14. Global Amfepramone(Diethylpropion) API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Amfepramone(Diethylpropion) API Sales by Company (2018-2023) & (Tons)
Table 16. Global Amfepramone(Diethylpropion) API Sales Market Share by Company (2018-2023)
Table 17. Global Amfepramone(Diethylpropion) API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Amfepramone(Diethylpropion) API Revenue Market Share by Company (2018-2023)
Table 19. Global Amfepramone(Diethylpropion) API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Amfepramone(Diethylpropion) API Producing Area Distribution and Sales Area
Table 21. Players Amfepramone(Diethylpropion) API Products Offered
Table 22. Amfepramone(Diethylpropion) API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Amfepramone(Diethylpropion) API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Amfepramone(Diethylpropion) API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Amfepramone(Diethylpropion) API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Amfepramone(Diethylpropion) API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Amfepramone(Diethylpropion) API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Amfepramone(Diethylpropion) API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Amfepramone(Diethylpropion) API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Amfepramone(Diethylpropion) API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Amfepramone(Diethylpropion) API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Amfepramone(Diethylpropion) API Sales Market Share by Country (2018-2023)
Table 35. Americas Amfepramone(Diethylpropion) API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Amfepramone(Diethylpropion) API Revenue Market Share by Country (2018-2023)
Table 37. Americas Amfepramone(Diethylpropion) API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Amfepramone(Diethylpropion) API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Amfepramone(Diethylpropion) API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Amfepramone(Diethylpropion) API Sales Market Share by Region (2018-2023)
Table 41. APAC Amfepramone(Diethylpropion) API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Amfepramone(Diethylpropion) API Revenue Market Share by Region (2018-2023)
Table 43. APAC Amfepramone(Diethylpropion) API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Amfepramone(Diethylpropion) API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Amfepramone(Diethylpropion) API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Amfepramone(Diethylpropion) API Sales Market Share by Country (2018-2023)
Table 47. Europe Amfepramone(Diethylpropion) API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Amfepramone(Diethylpropion) API Revenue Market Share by Country (2018-2023)
Table 49. Europe Amfepramone(Diethylpropion) API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Amfepramone(Diethylpropion) API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Amfepramone(Diethylpropion) API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Amfepramone(Diethylpropion) API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Amfepramone(Diethylpropion) API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Amfepramone(Diethylpropion) API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amfepramone(Diethylpropion) API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Amfepramone(Diethylpropion) API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Amfepramone(Diethylpropion) API
Table 58. Key Market Challenges & Risks of Amfepramone(Diethylpropion) API
Table 59. Key Industry Trends of Amfepramone(Diethylpropion) API
Table 60. Amfepramone(Diethylpropion) API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Amfepramone(Diethylpropion) API Distributors List
Table 63. Amfepramone(Diethylpropion) API Customer List
Table 64. Global Amfepramone(Diethylpropion) API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Amfepramone(Diethylpropion) API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Amfepramone(Diethylpropion) API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Amfepramone(Diethylpropion) API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Amfepramone(Diethylpropion) API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Amfepramone(Diethylpropion) API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Amfepramone(Diethylpropion) API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Amfepramone(Diethylpropion) API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Amfepramone(Diethylpropion) API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Amfepramone(Diethylpropion) API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Amfepramone(Diethylpropion) API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Amfepramone(Diethylpropion) API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Amfepramone(Diethylpropion) API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Amfepramone(Diethylpropion) API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Avantor Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 79. Avantor Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 80. Avantor Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Avantor Main Business
Table 82. Avantor Latest Developments
Table 83. Sanofi Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 85. Sanofi Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Pfizer Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 90. Pfizer Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Arevipharma Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 94. Arevipharma Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 95. Arevipharma Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Arevipharma Main Business
Table 97. Arevipharma Latest Developments
Table 98. Fiore Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 99. Fiore Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 100. Fiore Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Fiore Main Business
Table 102. Fiore Latest Developments
Table 103. ACS Dobfar Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 104. ACS Dobfar Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 105. ACS Dobfar Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. ACS Dobfar Main Business
Table 107. ACS Dobfar Latest Developments
Table 108. Tiefenbacher Group Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 109. Tiefenbacher Group Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 110. Tiefenbacher Group Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Tiefenbacher Group Main Business
Table 112. Tiefenbacher Group Latest Developments
Table 113. Varda Biotec Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 114. Varda Biotec Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 115. Varda Biotec Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Varda Biotec Main Business
Table 117. Varda Biotec Latest Developments
Table 118. Toronto Research Chemicals Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 119. Toronto Research Chemicals Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 120. Toronto Research Chemicals Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Toronto Research Chemicals Main Business
Table 122. Toronto Research Chemicals Latest Developments
Table 123. Radiant Pharma Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 124. Radiant Pharma Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 125. Radiant Pharma Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Radiant Pharma Main Business
Table 127. Radiant Pharma Latest Developments
Table 128. Overlack Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 129. Overlack Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 130. Overlack Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Overlack Main Business
Table 132. Overlack Latest Developments
Table 133. Jigs Chemical Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 134. Jigs Chemical Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 135. Jigs Chemical Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Jigs Chemical Main Business
Table 137. Jigs Chemical Latest Developments
Table 138. Biosynt Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 139. Biosynt Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 140. Biosynt Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Biosynt Main Business
Table 142. Biosynt Latest Developments
Table 143. Amfinecom Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 144. Amfinecom Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 145. Amfinecom Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Amfinecom Main Business
Table 147. Amfinecom Latest Developments
Table 148. USV Basic Information, Amfepramone(Diethylpropion) API Manufacturing Base, Sales Area and Its Competitors
Table 149. USV Amfepramone(Diethylpropion) API Product Portfolios and Specifications
Table 150. USV Amfepramone(Diethylpropion) API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. USV Main Business
Table 152. USV Latest Developments

LIST OF FIGURES

Figure 1. Picture of Amfepramone(Diethylpropion) API
Figure 2. Amfepramone(Diethylpropion) API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amfepramone(Diethylpropion) API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Amfepramone(Diethylpropion) API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amfepramone(Diethylpropion) API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Barreled
Figure 10. Product Picture of Bags
Figure 11. Global Amfepramone(Diethylpropion) API Sales Market Share by Type in 2022
Figure 12. Global Amfepramone(Diethylpropion) API Revenue Market Share by Type (2018-2023)
Figure 13. Amfepramone(Diethylpropion) API Consumed in Appetite Suppressant
Figure 14. Global Amfepramone(Diethylpropion) API Market: Appetite Suppressant (2018-2023) & (Tons)
Figure 15. Amfepramone(Diethylpropion) API Consumed in Others
Figure 16. Global Amfepramone(Diethylpropion) API Market: Others (2018-2023) & (Tons)
Figure 17. Global Amfepramone(Diethylpropion) API Sales Market Share by Application (2022)
Figure 18. Global Amfepramone(Diethylpropion) API Revenue Market Share by Application in 2022
Figure 19. Amfepramone(Diethylpropion) API Sales Market by Company in 2022 (Tons)
Figure 20. Global Amfepramone(Diethylpropion) API Sales Market Share by Company in 2022
Figure 21. Amfepramone(Diethylpropion) API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Amfepramone(Diethylpropion) API Revenue Market Share by Company in 2022
Figure 23. Global Amfepramone(Diethylpropion) API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Amfepramone(Diethylpropion) API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Amfepramone(Diethylpropion) API Sales 2018-2023 (Tons)
Figure 26. Americas Amfepramone(Diethylpropion) API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Amfepramone(Diethylpropion) API Sales 2018-2023 (Tons)
Figure 28. APAC Amfepramone(Diethylpropion) API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Amfepramone(Diethylpropion) API Sales 2018-2023 (Tons)
Figure 30. Europe Amfepramone(Diethylpropion) API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Amfepramone(Diethylpropion) API Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Amfepramone(Diethylpropion) API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Amfepramone(Diethylpropion) API Sales Market Share by Country in 2022
Figure 34. Americas Amfepramone(Diethylpropion) API Revenue Market Share by Country in 2022
Figure 35. Americas Amfepramone(Diethylpropion) API Sales Market Share by Type (2018-2023)
Figure 36. Americas Amfepramone(Diethylpropion) API Sales Market Share by Application (2018-2023)
Figure 37. United States Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Amfepramone(Diethylpropion) API Sales Market Share by Region in 2022
Figure 42. APAC Amfepramone(Diethylpropion) API Revenue Market Share by Regions in 2022
Figure 43. APAC Amfepramone(Diethylpropion) API Sales Market Share by Type (2018-2023)
Figure 44. APAC Amfepramone(Diethylpropion) API Sales Market Share by Application (2018-2023)
Figure 45. China Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Amfepramone(Diethylpropion) API Sales Market Share by Country in 2022
Figure 53. Europe Amfepramone(Diethylpropion) API Revenue Market Share by Country in 2022
Figure 54. Europe Amfepramone(Diethylpropion) API Sales Market Share by Type (2018-2023)
Figure 55. Europe Amfepramone(Diethylpropion) API Sales Market Share by Application (2018-2023)
Figure 56. Germany Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Amfepramone(Diethylpropion) API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Amfepramone(Diethylpropion) API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Amfepramone(Diethylpropion) API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Amfepramone(Diethylpropion) API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Amfepramone(Diethylpropion) API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Amfepramone(Diethylpropion) API in 2022
Figure 71. Manufacturing Process Analysis of Amfepramone(Diethylpropion) API
Figure 72. Industry Chain Structure of Amfepramone(Diethylpropion) API
Figure 73. Channels of Distribution
Figure 74. Global Amfepramone(Diethylpropion) API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Amfepramone(Diethylpropion) API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Amfepramone(Diethylpropion) API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Amfepramone(Diethylpropion) API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Amfepramone(Diethylpropion) API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Amfepramone(Diethylpropion) API Revenue Market Share Forecast by Application (2024-2029)


More Publications